Critical Care
BioMed Central
Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients
Volume: 24
DOI 10.1186/s13054-020-03001-6
  • PDF   
  • XML   
Despres, Brunin, Berthier, Pili-Floury, and Besch: Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients

Dear Editor,

A massive outbreak of coronavirus disease 2019 (Covid-19) occurred in France in March and April 2020. About 20% of Covid-19 patients develop acute respiratory distress syndrome (ARDS), with mortality ranging from 20 to 50%. Since the publication of the PROSEVA study [1], prone positioning (PP) has become a cornerstone of management of mechanically ventilated severe ARDS patients.

Recently, PP was reported to enhance oxygenation when combined with high-flow nasal cannula in severe non-Covid-19 ARDS [2, 3] and to improve lung recruitability when combined with non-invasive ventilation in severe Covid-19 ARDS [4].

We report the case of 6 severe Covid-19 patients admitted to our critical care unit between March and April 2020, who had PP combined with either high-flow nasal oxygen (HFNO) or conventional oxygen therapy (COT). All patients had laboratory-confirmed SARS-CoV-2 infection, defined as a positive result of real-time reverse transcriptase-polymerase chain reaction (RT-PCT) from nasal and pharyngeal swabs. ARDS was defined according to the Berlin definition, with a ratio of PaO2 to FiO2 (PaO2/FiO2) ≤ 300 mmHg. All patients presented rapid worsening of dyspnea and oxygenation, defined as SpO2 ≤ 92% despite increasing oxygen supply to more than ≥ 5 L/min. All patients were spontaneously ventilated, and no patient had criteria that indicated the need for emergency intubation. All patients had predominant posterior lung condensation documented either on lung ultrasound or CT-scan.

HFNO or COT was prescribed to reach SpO2  ≥ 94%. The clinical course of ARDS was closely followed using the ROX index [5]. PP was proposed to patients who presented clinical worsening, as persistent hypoxia despite increasing oxygen delivery, or a decrease in the ROX index. PP was maintained depending on patient clinical tolerance and could be repeated if necessary.

Relevant clinical, laboratory data and HFNO or COT settings were obtained from medical records and are presented in Table 1.

Table 1
Clinical characteristics and outcomes of patients
Case no.GenderAge (years)SAPS II score at admissionVentilatory supportBMI (kg.m−2)Duration of prone positioning (hours)PaO2/FiO2 before prone positionPaO2/FiO2 after prone positionIntubation
1Male6027HFNO 50 L/min277144254Yes
2Male5432COT 6 L/min271215147No
HFNO 50 L/min1129156
3Male5526HFNO 50 L/min2616126194No
HFNO 50 L/min16183162
4Male6637COT 5 L/min314150242Yes
5Male6128COT 3 L/min211274225Yes
COT 3 L/min2193124
6Male6436COT 5 L/min272212168No

FiO2 with COT was calculated using the following formula: FiO2 = 21 + (4 × oxygen flow rate in L min−1)

BMI body mass index, HFNO high-flow nasal oxygen, COT conventional oxygen therapy

A total of 9 PP sessions was performed in 6 patients. PP was combined with HFNO in 4 sessions and to COT in 5 sessions. The PaO2/FiO2 ratio improved after 4 sessions, including 3 sessions combined with HFNO and 1 session combined with COT. Intubation was avoided in 3 patients.

This is the first report of PP combined with either HFNO or COT in severe Covid-19 pneumonia. The proportion of patients with PaO2/FiO2 ratio improvement after PP appeared to be higher with HFNO compared to conventional oxygen therapy, suggesting the need for a high flow of oxygen to provide a significant oxygen response [6]. All patients described subjective enhancement of dyspnea after prone positioning, but this data was not quantified. The efficacy of PP combined with HFNO therapy or non-invasive ventilation was recently reported in small cohorts of non-infectious and infectious non-Covid-19 ARDS patients [2, 3]. Interestingly, the proportion of patients with an improvement in PaO2/FiO2 ratio and the rate of intubation avoided in these 2 studies were very close to that observed in the present series of 6 severe Covid-19 patients.

Considering these observations, PP combined with either HFNO or COT could be proposed in spontaneously breathing, severe Covid-19 patients to avoid intubation. The indication for PP in non-intubated Covid-19 pneumonia needs to be addressed in further studies.


Publisher’s Note:

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


The authors thank Fiona Ecarnot, Ph.D., University Hospital of Besancon and University of Franche-Comte, Besancon, France, for her assistance in preparing the manuscript.

Authors’ contributions

Cyrielle Despres, Yannick Brunin, Francis Berthier, Sebastien Pili-Floury, and Guillaume Besch had substantial contributions to conception and design of the study, acquisition and interpretation of data, and drafting of the article manuscript. The author(s) read and approved the final manuscript.


No funding to report.

Availability of data and materials

Not applicable.

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors have no conflict of interest to disclose.



    Guérin C, Reignier J, Richard J-C, Beuret P, Gacouin A, Boulain T, . Prone positioning in severe acute respiratory distress syndrome. N Engl J Med 2013. 368: , pp.2159-2168, doi: 10.1056/NEJMoa1214103


    Ding L, Wang L, Ma W, He H. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study. Crit Care 2020. 24: , pp.28, doi: 10.1186/s13054-020-2738-5


    Pérez-Nieto OR, Guerrero-Gutiérrez MA, Deloya-Tomas E, Ñamendys-Silva SA. Prone positioning combined with high-flow nasal cannula in severe noninfectious ARDS. Crit Care 2020. 24: , pp.114, doi: 10.1186/s13054-020-2821-y


    Pan Chun, Chen Lu, Lu Cong, Zhang Wei, Xia Jia-An, Sklar Michael C., Du Bin, Brochard Laurent, Qiu Haibo. Lung Recruitability in COVID-19–associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study. American Journal of Respiratory and Critical Care Medicine 2020. 201: 10, pp.1294-1297, doi: 10.1164/rccm.202003-0527LE


    Roca O, Caralt B, Messika J, Samper M, Sztrymf B, Hernández G, . An index combining respiratory rate and oxygenation to predict outcome of nasal high-flow therapy. Am J Respir Crit Care Med 2019. 199: , pp.1368-1376, doi: 10.1164/rccm.201803-0589OC


    Scaramuzzo G, Ball L, Pino F, Ricci L, Larsson A, Guérin C, . Influence of positive end-expiratory pressure titration on the effects of pronation in acute respiratory distress syndrome: a comprehensive experimental study. Front Physiol 2020. 11: , pp.179, doi: 10.3389/fphys.2020.00179 positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients&author=Cyrielle Despres,Yannick Brunin,Francis Berthier,Sebastien Pili-Floury,Guillaume Besch,&keyword=&subject=Research Letter,